Ardigen Representatives Share Expertise with Silesian University of Technology Students

Topic:

Sharing knowledge lies closely to Ardigen’s philosophy. In that spirit Ardigen’s bioinformaticians – Magdalena Ochab and Bożena Mika-Gospodorz – led a discussion panel with students at the Silesian University of Technology.

The Students’ Meeting with scRNA Seq Data Processing through Ardigen’s Lenses

Our experts’ presentation – “scRNA-Seq data processing with Nextflow pipeline and Python packages” – sparked a lively discussion among students. We are thrilled to see that, as contributing to scientific advancement lies close to Ardigen’s ideals.

Magdalena and Bożena’s contribution to the academic discussion in the bioinformatics fields is commendable. Thank you for your commitment to sharing knowledge and bridging industry expertise with academic curiosity!

About Silesian University of Technology:

Silesian University of Technology (SUT) is a large and prestigious technical university in Upper Silesia, Poland. Established in 1945, it conducts innovative scientific research and development, educates highly qualified staff for the knowledge-based society and economy, and actively engages with the region and local communities’ development.

The university continuously improves its processes and organization. It remains a friendly and open place for the academic community to work and develop. See their website for more information: https://www.polsl.pl/en/

You might be also interested in:

The role of AI CROs in the next wave of biopharma transformation)
AI CROs and the Pharma Shift: The Next Wave of Drug Discovery Innovation
AI hit-to-lead optimization for drug discovery
AI brain neurological diseases
Uncovering novel targets and approaches to treating neurological diseases

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!